Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
Clinical trial NCT03371693 · UNKNOWN
Trial details
- NCT number
- NCT03371693
- Sponsor
- Zhongnan Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-30
- Primary completion
- 2022-12-30
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.